Cross-Sector entity

FulcrumSec

organization
8.4

Of the tracked stories, 7 of 9 also mention Novo Nordisk, the most common co-covered peer. The 12-day window averages about 5.3 stories each week. The busiest single day carried 4. health-it accounts for 2 of the 9 tracked stories, while 5 other categories carry the remainder.

9 verified stories tracked

Last mentioned: Jun 28, 2026

Entity pulse

Recent coverage · FulcrumSec

9 stories
8.4 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about FulcrumSec

Of the tracked stories, 7 of 9 also mention Novo Nordisk, the most common co-covered peer. The 12-day window averages about 5.3 stories each week. The busiest single day carried 4. health-it accounts for 2 of the 9 tracked stories, while 5 other categories carry the remainder. We currently track 9 Cross-Sector stories that mention FulcrumSec, published between June 17, 2026 and June 28, 2026. Negative sentiment appears in 100% of the tracked stories. Each carries 2.3 original sources on average.

Stories tracked
9
Per week
5.3
Negative
100%
Sources per story
2.3

Computed from the 9 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering FulcrumSec. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. FulcrumSec Goes Public

    FulcrumSec posts a lengthy message on its website detailing the breach, the $25 million extortion demand, and the decision to explore private data sales after payment refusal.

  2. ShinyHunters announces additional victims

    On June 16, the group reveals new targets including Glendale Community College, Moody Bible Institute, Illinois Central College, and Houston City College.

  3. Company Discloses Breach

    Novo Nordisk publicly announces a cybersecurity incident involving unauthorized access to a limited number of internal IT systems and some personal data.

  4. Public incident disclosure

    Novo Nordisk announces a cybersecurity incident involving unauthorized access to a limited number of internal IT systems and access to certain personal data.

  5. Novo Nordisk Responds

    Roughly 48 hours after initial outreach, Novo Nordisk uses a Proton Mail address to verify the legitimacy of the claim by requesting specific file contents.

  6. Initial Extortion Contact

    FulcrumSec contacts unnamed Novo Nordisk executives demanding $25 million; the exact method is not publicly detailed.

  7. FulcrumSec ransomware attack on Global Schools Foundation

    The group exfiltrates data and disrupts operations across GSF's international network of schools in early June, causing widespread service outages.

  8. Extortion demand sent

    The group contacts unnamed Novo Nordisk executives and demands $25 million, initiating the extortion phase.

  9. Suspected initial intrusion

    FulcrumSec likely gains initial access to Novo Nordisk's networks, beginning a period of over two months of undetected data exfiltration.

  10. ShinyHunters breaches Infinite Campus via Salesforce

    Cybercriminals exploit a vulnerability to steal personal information from 137,000 school staff accounts, affecting the widely used K-12 student information system.

  11. FulcrumSec Emerges

    The cyber extortion group FulcrumSec first appears, later becoming known for credible claims and sophisticated intrusions.

Stories mentioning FulcrumSec 9

Healthcare health it Strongly negative 8

1TB of Patient Data Exposed in Novo Nordisk Hack, $25M Extortion Attempt

A cyberattack on Novo Nordisk has potentially exposed over a terabyte of sensitive health information, including patient, doctor, and clinical trial data, after a $25 million extortion demand was refused. The incident highlights critical vulnerabilities in protecting personal health data within the pharmaceutical industry.

3 sources
Cyber threat intel Strongly negative 8

FulcrumSec's 2-Month Intrusion at Novo Nordisk Yields 1TB Data, $25M Ransom

Cyber extortion group FulcrumSec executed a sophisticated, two-month-long network intrusion at Novo Nordisk, exfiltrating 1TB of sensitive data and demanding $25 million. The group's tactics and the refusal to pay offer a detailed case study for threat intelligence and incident response teams.

3 sources
Cyber data breach Negative 8

ShinyHunters & FulcrumSec Ramp Up EdTech Attacks: 137K Accounts Stolen

Two major threat actor groups are driving a crisis in education technology, with ShinyHunters stealing 137,000 staff records via Infinite Campus and FulcrumSec paralyzing Global Schools Foundation. The incidents reveal a shift in cybercriminal focus toward low-defence, high-value academic data repositories.

2 sources
Healthcare health it Strongly negative 9

1 TB of Novo Nordisk Data Stolen: 11,500 Clinical Trial Patients Exposed

A cyber extortion group claims to have stolen over a terabyte of data from pharmaceutical giant Novo Nordisk, including clinical trial data of 11,500 patients. While some sensitive data is being withheld, the breach highlights critical vulnerabilities in healthcare data security and could trigger regulatory scrutiny under GDPR and other frameworks.

2 sources
Cyber threat intel Strongly negative 9

FulcrumSec Spent 2 Months Inside Novo Nordisk Networks Before $25M Demand

Cybersecurity experts assess FulcrumSec as a serious threat actor, and its two-month dwell time inside Novo Nordisk before making a $25 million extortion demand reflects advanced persistent threat tactics. The breach highlights growing risks to critical infrastructure and the evolution of cyber extortion with a harm-reduction narrative.

2 sources
Biotech pharma Strongly negative 9

$25M Extortion Bid Exposes Novo Nordisk’s Unreleased Drug Pipeline

FulcrumSec's breach of Novo Nordisk could jeopardize years of R&D as stolen data includes proprietary information on released and unreleased drugs, trial data, and manufacturing processes. With the extortion failure and potential data sale, rival pharma firms may gain competitive intelligence, threatening Novo's market position.

2 sources